Metabolic Syndrome linked to bladder Cancer Risk: Study Dr. Shravani Dali29 May 2025 8:45 PM ISTResearchers have found in a new study that Metabolic Syndrome is linked to bladder Cancer Risk. It revealed that components of MetS—such as diabetes,...
AstraZeneca Imfinzi recommended for approval in EU for adults with muscle-invasive bladder cancer Ruchika Sharma29 May 2025 2:15 PM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) for the...
Combining radiation and immunotherapy shows promise for bladder cancer Dr. Kamal Kant Kohli27 May 2025 8:30 PM ISTA new review was published in Volume 16 of Oncotarget on May 19, 2025, titled "Advancements in bladder cancer treatment: The synergy of radiation and...
Neoadjuvant chemotherapy in bladder cancer treated with open radical cystectomy improved prognosis: Study Jacinthlyn Sylvia27 April 2025 9:00 PM ISTA new study published in the International Journal of Urology showed that patients with muscle-invasive bladder cancer (MIBC) undergoing radical...
Second TB vaccination boosts immunity in bladder cancer patients and reduces cancer recurrence: Study Dr. Kamal Kant Kohli23 April 2025 9:15 PM ISTTwo doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly improve patient outcomes for...
AstraZeneca gets USFDA approval for perioperative Imfinzi for bladder cancer Ruchika Sharma1 April 2025 2:15 PM ISTImfinzi was generally well tolerated, and no new safety signals were observed in the neoadjuvant and adjuvant settings.
Medical Bulletin 23/ January/ 2025 Dr. Bhumika Maikhuri23 Jan 2025 3:00 PM ISTHere are the top medical news for the day:At-Home Bladder Cancer Test: New Urine-Based Kit May Enable Early DiagnosisThe research team has developed a...
At-Home Bladder Cancer Test: New Urine-Based Kit May Enable Early Diagnosis, Study Finds Dr. Bhumika Maikhuri23 Jan 2025 8:00 AM ISTThe research team has developed a urine-based diagnostic kit for bladder cancer that can be conveniently used at home. This kit can accurately detect...
JnJ initiates submission of New Drug Application with USFDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer Ruchika Sharma16 Jan 2025 12:30 PM ISTRaritan: Johnson & Johnson has announced it has initiated the submission of an original New Drug Application with the U.S. Food and Drug...
Pfizer Sasanlimab, BCG combo improves event-free survival in patients with BCG-Naive, High-Risk Non-Muscle Invasive Bladder Cancer Ruchika Sharma15 Jan 2025 10:30 AM ISTNew York: Pfizer Inc. has announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational...
AstraZeneca Imfinzi granted priority review by USFDA for muscle-invasive bladder cancer Ruchika Sharma7 Dec 2024 12:30 PM ISTCambridge: AstraZeneca's supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has been accepted and granted Priority Review...
Gilead withdraws bladder cancer drug Trodelvy in US Farhat Nasim20 Oct 2024 11:00 AM ISTBengaluru: Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for previously treated patients with a type of bladder...
